Palbociclib and Sorafenib, Decitabine, or Dexamethasone in Treating Patients With Recurrent or Refractory Leukemia
M.D. Anderson Cancer Center
M.D. Anderson Cancer Center
M.D. Anderson Cancer Center
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
University of Virginia
Roswell Park Cancer Institute
Massachusetts General Hospital
University of Chicago
Dana-Farber Cancer Institute
St. Jude Children's Research Hospital
Dana-Farber Cancer Institute